Identification of a novel inhibitor targeting influenza A virus group 2 hemagglutinins

SPECIAL REPORT

HIV / AIDS

11^e Conférence de la Société internationale sur le SIDA (IAS) 2021

Viral Infections, Non-HIV

CHARACTERIZATION OF INFLUENZA B VIRUS VARIANTS WITH REDUCED NEURAMINIDASE INHIBITOR SUSCEPTIBILITY

Antimicrob Agents Chemother.

Farrukee R, Zarebski AE, McCaw JM, Bloom JD, Reading PC, Hurt AC

doi: 10.1128/AAC.01081-18.

Viral Infections, Non-HIV

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

Viruses.

Ahmed SF, Quadeer AA, McKay MR

doi: 10.3390/v12030254.

Viral Infections, Non-HIV

Antivirals targeting the polymerase complex of influenza viruses

Antiviral Res.

Mifsud EJ, Hayden FG, Hurt AC

doi: 10.1016/j.antiviral.2019.104545.

SPECIAL REPORT

HIV / AIDS

11. Konferenz der Internationalen AIDS-Gesellschaft (IAS) 2021

HIV / AIDSViral Infections, Non-HIV

Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses

Antiviral Res.

Hu Y, Zhang J, Musharrafieh RG, Ma C, Hau R, Wang J

doi: 10.1016/

Viral Infections, Non-HIV

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors)

Clin Microbiol Infect.

Redelman-Sidi G, Michielin O, Cervera C, Ribi C, Aguado JM, Fernández-Ruiz M, Manuel O

doi: 10.1016/j.cmi.2018.01.030.

Viral Infections, Non-HIV

A Novel Vaccine Employing Non-Replicating Rabies Virus Expressing Chimeric SARS-CoV-2 Spike Protein Domains: Functional Inhibition of Viral/Nicotinic Acetylcholine Receptor Complexes

Med Sci Monit.

Stefano ML, Kream RM, Stefano GB

doi: 10.12659/MSM.926016.

Viral Infections, Non-HIV

The role of extracellular histones in influenza virus pathogenesis

Am J Pathol.

Ashar HK, Mueller NC, Rudd JM, Snider TA, Achanta M, Prasanthi M, Pulavendran S, Thomas PG, Akhilesh R, Malayer JR, Ritchey JW, Rajasekhar R, Chow VT, Esmon CT, Teluguakula N

doi: 10.1016/j.ajpath.2017.09.014.

Related content

11e Conférence de la Société internationale sur le SIDA (IAS) 2021

CHARACTERIZATION OF INFLUENZA B VIRUS VARIANTS WITH REDUCED NEURAMINIDASE INHIBITOR SUSCEPTIBILITY

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

Antivirals targeting the polymerase complex of influenza viruses

11. Konferenz der Internationalen AIDS-Gesellschaft (IAS) 2021

Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors)

A Novel Vaccine Employing Non-Replicating Rabies Virus Expressing Chimeric SARS-CoV-2 Spike Protein Domains: Functional Inhibition of Viral/Nicotinic Acetylcholine Receptor Complexes

The role of extracellular histones in influenza virus pathogenesis

11^e Conférence de la Société internationale sur le SIDA (IAS) 2021